News
Vinay Prasad, a top official at the Food and Drug Administration, has suddenly departed after a series of controversial ...
MyChesCo on MSN18m
Aclaris Therapeutics Taps Veteran Biotech Leader Roland Kolbeck as New Chief Scientific OfficerAclaris Therapeutics, Inc. (NASDAQ: ACRS) announced the appointment of Roland Kolbeck, Ph.D., as its new Chief Scientific ...
The FDA has cleared investigational new drug applications for ZW251 and RV‑01, advancing novel treatments for solid tumors in first-in-human trials.
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...
Thomas Newsom, president of Southeastern Oklahoma State University, has been named president of Pittsburg State University, ...
NeuroScientific Biopharmaceuticals has made a second heavy-hitting appointment, with Melbourne-based exec Nathan Smith ...
In India, Zaynich will be positioned as a third-line treatment, primarily for ICU patients when other antibiotics have failed ...
Professor Robin May is stepping down after completing a five-year term in the role, and will take up a new position as ...
Illinois Gov. JB Pritzker and former U.S. Commerce Secretary Penny Pritzker are at the center of an effort to drive more ...
The House Judiciary Committee ordered Dr. Philip Dormitzer, the ex-vice president and chief scientific officer of RNA and viral vaccines for Pfizer, to appear for a deposition on July 22.
Roland Kolbeck, Ph.D. Appointed as Chief Scientific Officer - - Joe Monahan, Ph.D. will Continue to Support Aclaris as Special Scientific Advisor to the Chief Executive Officer through March 2026 as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback